ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
- Author
- POSPISILOVA, S1 ; GONZALEZ, D2 ; HILLMEN, P8 ; OERS, M. Van4 ; GRIBBEN, J9 ; GHIA, P10 ; MONTSERRAT, E11 ; STILGENBAUER, S7 ; ZENZ, T12 13 ; MALCIKOVA, J1 ; TRBUSEK, M1 ; ROSSI, D3 ; KATER, A. P4 ; CYMBALISTA, F5 ; EICHHORST, B6 ; HALLEK, M6 ; DÖHNER, H7
[1] Central European Institute of Technology, Masaryk University and Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
[2] Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
[3] Department of Translational Medicine, Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
[4] Department of Hematology, Academic Medical Center, Amsterdam, Netherlands
[5] Hôpital Avicenne, Université Paris XIII, Laboratoire d'hématologie, Bobigny, France
[6] Department of Internal Medicine I, Center for Integrated Oncology Köln-Bonn, University of Cologne, Cologne, Germany
[7] Department of Internal Medicine III, University of Ulm, Ulm, Germany
[8] Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, United Kingdom
[9] Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
[10] Laboratory of B-cell Neoplasia, Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy
[11] Department of Hematology, Institute of Hematology and Oncology, Hospital Clinic, Barcelona, IDIBAP, University of Barcelona, Barcelona, Spain
[12] Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany
[13] Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany - Source
Leukemia. 2012, Vol 26, Num 7, pp 1458-1461, 4 p ; ref : 30 ref
- CODEN
- LEUKED
- ISSN
- 0887-6924
- Scientific domain
- Medical oncology; Hematology
- Publisher
- Nature Publishing Group, Avenel, NJ
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- CLL TP53 mutation
- Keyword (fr)
- Gène TP53 Gène suppresseur tumeur Génétique Hématologie Leucémie lymphoïde chronique Mutation Recommandation Cancer Hémopathie maligne Syndrome lymphoprolifératif
- Keyword (en)
- TP53 Gene Tumor suppressor gene Genetics Hematology Chronic lymphocytic leukemia Mutation Recommendation Cancer Malignant hemopathy Lymphoproliferative syndrome
- Keyword (es)
- Gen TP53 Gen supresor tumor Genética Hematología Leucemia linfoidea crónica Mutación Recomendación Cáncer Hemopatía maligna Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26128202
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/leu.2012.25 
https://dx.doi.org/10.1038/leu.2012.25
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/leu.2012.25\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1458\";s:8:\"\u0000*\u0000epage\";s:4:\"1461\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"POSPISILOVA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"GONZALEZ, D\";i:1;s:10:\"HILLMEN, P\";i:2;s:12:\"OERS, M. Van\";i:3;s:10:\"GRIBBEN, J\";i:4;s:7:\"GHIA, P\";i:5;s:13:\"MONTSERRAT, E\";i:6;s:15:\"STILGENBAUER, S\";i:7;s:7:\"ZENZ, T\";i:8;s:12:\"MALCIKOVA, J\";i:9;s:10:\"TRBUSEK, M\";i:10;s:8:\"ROSSI, D\";i:11;s:11:\"KATER, A. P\";i:12;s:13:\"CYMBALISTA, F\";i:13;s:12:\"EICHHORST, B\";i:14;s:9:\"HALLEK, M\";i:15;s:10:\"D\u00d6HNER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:8:\"\u0000*\u0000place\";s:10:\"Avenel, NJ\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/leu.2012.25\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1458\";s:8:\"\u0000*\u0000epage\";s:4:\"1461\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"POSPISILOVA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"GONZALEZ, D\";i:1;s:10:\"HILLMEN, P\";i:2;s:12:\"OERS, M. Van\";i:3;s:10:\"GRIBBEN, J\";i:4;s:7:\"GHIA, P\";i:5;s:13:\"MONTSERRAT, E\";i:6;s:15:\"STILGENBAUER, S\";i:7;s:7:\"ZENZ, T\";i:8;s:12:\"MALCIKOVA, J\";i:9;s:10:\"TRBUSEK, M\";i:10;s:8:\"ROSSI, D\";i:11;s:11:\"KATER, A. P\";i:12;s:13:\"CYMBALISTA, F\";i:13;s:12:\"EICHHORST, B\";i:14;s:9:\"HALLEK, M\";i:15;s:10:\"D\u00d6HNER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:8:\"\u0000*\u0000place\";s:10:\"Avenel, NJ\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/leu.2012.25\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/leu.2012.25\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1458\";s:8:\"\u0000*\u0000epage\";s:4:\"1461\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"POSPISILOVA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"GONZALEZ, D\";i:1;s:10:\"HILLMEN, P\";i:2;s:12:\"OERS, M. Van\";i:3;s:10:\"GRIBBEN, J\";i:4;s:7:\"GHIA, P\";i:5;s:13:\"MONTSERRAT, E\";i:6;s:15:\"STILGENBAUER, S\";i:7;s:7:\"ZENZ, T\";i:8;s:12:\"MALCIKOVA, J\";i:9;s:10:\"TRBUSEK, M\";i:10;s:8:\"ROSSI, D\";i:11;s:11:\"KATER, A. P\";i:12;s:13:\"CYMBALISTA, F\";i:13;s:12:\"EICHHORST, B\";i:14;s:9:\"HALLEK, M\";i:15;s:10:\"D\u00d6HNER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:8:\"\u0000*\u0000place\";s:10:\"Avenel, NJ\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/leu.2012.25\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1458\";s:8:\"\u0000*\u0000epage\";s:4:\"1461\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"POSPISILOVA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"GONZALEZ, D\";i:1;s:10:\"HILLMEN, P\";i:2;s:12:\"OERS, M. Van\";i:3;s:10:\"GRIBBEN, J\";i:4;s:7:\"GHIA, P\";i:5;s:13:\"MONTSERRAT, E\";i:6;s:15:\"STILGENBAUER, S\";i:7;s:7:\"ZENZ, T\";i:8;s:12:\"MALCIKOVA, J\";i:9;s:10:\"TRBUSEK, M\";i:10;s:8:\"ROSSI, D\";i:11;s:11:\"KATER, A. P\";i:12;s:13:\"CYMBALISTA, F\";i:13;s:12:\"EICHHORST, B\";i:14;s:9:\"HALLEK, M\";i:15;s:10:\"D\u00d6HNER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:8:\"\u0000*\u0000place\";s:10:\"Avenel, NJ\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1038\/leu.2012.25\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:9:\"\u0000*\u0000jtitle\";s:8:\"Leukemia\";s:9:\"\u0000*\u0000stitle\";s:8:\"Leukemia\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1458\";s:8:\"\u0000*\u0000epage\";s:4:\"1461\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0887-6924\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"POSPISILOVA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:11:\"GONZALEZ, D\";i:1;s:10:\"HILLMEN, P\";i:2;s:12:\"OERS, M. Van\";i:3;s:10:\"GRIBBEN, J\";i:4;s:7:\"GHIA, P\";i:5;s:13:\"MONTSERRAT, E\";i:6;s:15:\"STILGENBAUER, S\";i:7;s:7:\"ZENZ, T\";i:8;s:12:\"MALCIKOVA, J\";i:9;s:10:\"TRBUSEK, M\";i:10;s:8:\"ROSSI, D\";i:11;s:11:\"KATER, A. P\";i:12;s:13:\"CYMBALISTA, F\";i:13;s:12:\"EICHHORST, B\";i:14;s:9:\"HALLEK, M\";i:15;s:10:\"D\u00d6HNER, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LEUKED\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia\";s:8:\"\u0000*\u0000place\";s:10:\"Avenel, NJ\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
